{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:11:35Z","timestamp":1793747495501,"version":"4.6.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital Eastern Branch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.autrev.2025.103755","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T06:19:17Z","timestamp":1737526757000},"page":"103755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Frequency of autoantibodies and their associated clinical characteristics and outcomes in patients with dilated cardiomyopathy: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"24","author":[{"given":"Jingdi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103755_bb0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-med-052422-020535","article-title":"Genetics of dilated cardiomyopathy","volume":"75","author":"Eldemire","year":"2024","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.autrev.2025.103755_bb0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/joim.13556","article-title":"Dilated cardiomyopathy and chronic cardiac inflammation: pathogenesis, diagnosis and therapy","volume":"293","author":"Harding","year":"2023","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2025.103755_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103386","article-title":"Functional autoantibodies: definition, mechanisms, origin and contributions to autoimmune and non-autoimmune disorders","volume":"22","author":"Yu","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103755_bb0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1388-9842(02)00010-7","article-title":"Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance","volume":"4","author":"Caforio","year":"2002","journal-title":"Eur J Heart Fail"},{"issue":"92\u20139","key":"10.1016\/j.autrev.2025.103755_bb0025","article-title":"Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy","volume":"156","author":"Landsberger","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2025.103755_bb0030","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/eurjhf\/hfs082","article-title":"The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure","volume":"14","author":"Pei","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.autrev.2025.103755_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052911","article-title":"beta1-adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the beta1-AR\/cAMP\/PKA and p38 MAPK pathways","volume":"7","author":"Du","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103755_bb0040","first-page":"1127","article-title":"Autoantibodies against the myocardial beta1-adrenergic and M2-muscarinic receptors in patients with congestive heart failure","volume":"115","author":"Zhang","year":"2002","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.autrev.2025.103755_bb0045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/hrt.67.5.402","article-title":"HLA-DR antigen linkage of anti-beta receptor antibodies in idiopathic dilated and ischaemic cardiomyopathy","volume":"67","author":"Limas","year":"1992","journal-title":"Br Heart J"},{"key":"10.1016\/j.autrev.2025.103755_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006155","article-title":"\u03b2(1)-Adrenoreceptor autoantibodies in heart failure: physiology and therapeutic implications","volume":"13","author":"D\u00fcngen","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.autrev.2025.103755_bb0055","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrcardio.2017.61","article-title":"Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias","volume":"14","author":"Lazzerini","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.autrev.2025.103755_bb0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.autrev.2018.12.005","article-title":"Lethal immunoglobulins: autoantibodies and sudden cardiac death","volume":"18","author":"Ryabkova","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103755_bb0065","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.hlc.2018.03.008","article-title":"Significance of anti-myosin antibody formation in patients with myocardial infarction: a prospective observational study","volume":"28","author":"O\u2019Donohoe","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.autrev.2025.103755_bb0070","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0735-1097(00)01109-8","article-title":"Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy","volume":"37","author":"Iwata","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2025.103755_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/08916939508993354","article-title":"Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptors","volume":"21","author":"Matsui","year":"1995","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2025.103755_bb0080","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.CIR.99.5.649","article-title":"Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure","volume":"99","author":"Jahns","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2025.103755_bb0085","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0735-1097(00)00881-0","article-title":"Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies","volume":"36","author":"Jahns","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2025.103755_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.autrev.2025.103755_bb0095","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1172\/JCI114888","article-title":"Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy","volume":"86","author":"Magnusson","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2025.103755_bb0100","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1172\/JCI116416","article-title":"Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy","volume":"91","author":"Fu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2025.103755_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/clin.1994.1101","article-title":"Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension","volume":"72","author":"Fu","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2025.103755_bb0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/08916939908995971","article-title":"Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages","volume":"29","author":"Liu","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2025.103755_bb0115","first-page":"42","article-title":"Prevalence of detection of autoantibodies to beta-1 adrenoreceptors in patients with myocarditides and cardiomyopathies","volume":"42","author":"Tabak\u2019ian","year":"2002","journal-title":"Kardiologiia"},{"key":"10.1016\/j.autrev.2025.103755_bb0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-8411(03)00042-8","article-title":"Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy","volume":"20","author":"Mobini","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103755_bb0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/08916930400011684","article-title":"Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody","volume":"37","author":"Larsson","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2025.103755_bb0130","doi-asserted-by":"crossref","first-page":"H1928","DOI":"10.1152\/ajpheart.00044.2004","article-title":"Sera from patients with idiopathic dilated cardiomyopathy decrease ICa in cardiomyocytes isolated from rabbits","volume":"287","author":"Del Corsso","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.autrev.2025.103755_bb0135","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ahj.2006.05.004","article-title":"Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy","volume":"152","author":"Stork","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2025.103755_bb0140","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCRESAHA.112.272682","article-title":"Detection of anti-beta1-AR autoantibodies in heart failure by a cell-based competition ELISA","volume":"111","author":"Holthoff","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2025.103755_bb0145","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cvr\/cvs350","article-title":"Impact of human autoantibodies on beta1-adrenergic receptor conformation, activity, and internalization","volume":"97","author":"Bornholz","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.autrev.2025.103755_bb0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12872-022-02461-8","article-title":"The abnormal distribution of peripheral B1 cells and transition B cells in patients with idiopathic dilated cardiomyopathy: a pilot study","volume":"22","author":"Tang","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.autrev.2025.103755_bb0155","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ehj.2004.05.012","article-title":"Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy","volume":"25","author":"Baba","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2025.103755_bb0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cardfail.2008.02.009","article-title":"Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy","volume":"14","author":"Miettinen","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.autrev.2025.103755_bb0165","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2006.04.077","article-title":"Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy","volume":"117","author":"Shmilovich","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2025.103755_bb0170","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/eurheartj\/ehn268","article-title":"Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction","volume":"29","author":"Leuschner","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2025.103755_bb0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1752-8062.2011.00313.x","article-title":"Cellular proliferative response to cardiac troponin-I in patients with idiopathic dilated cardiomyopathy","volume":"4","author":"Lappe","year":"2011","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.autrev.2025.103755_bb0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ahj.2008.02.015","article-title":"Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy","volume":"156","author":"Landsberger","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2025.103755_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00395-010-0126-z","article-title":"Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy","volume":"106","author":"Doesch","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.autrev.2025.103755_bb0190","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0022-2828(85)80029-8","article-title":"Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy","volume":"17","author":"Schultheiss","year":"1985","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.autrev.2025.103755_bb0195","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1253\/jcj.57.1150","article-title":"Auto-antibody against adenine nucleotide translocator in dilated cardiomyopathy and myocarditis--incidence and relation to cardiac function and morphology","volume":"57","author":"Takemoto","year":"1993","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.autrev.2025.103755_bb0200","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/jmcc.2002.1538","article-title":"Epitope mapping of mitochondrial adenine nucleotide translocase-1 in idiopathic dilated cardiomyopathy","volume":"34","author":"Manchado","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.autrev.2025.103755_bb0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3892\/mmr.2014.2146","article-title":"Increased circulating T-helper 22 cells in patients with dilated cardiomyopathy","volume":"10","author":"Kong","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.autrev.2025.103755_bb0210","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/hrt.74.6.598","article-title":"Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy","volume":"74","author":"Goldman","year":"1995","journal-title":"Br Heart J"},{"key":"10.1016\/j.autrev.2025.103755_bb0215","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/bbrc.1999.0761","article-title":"Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients","volume":"259","author":"Warraich","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2025.103755_bb0220","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/01.CIR.85.5.1734","article-title":"Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy","volume":"85","author":"Caforio","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2025.103755_bb0225","first-page":"62","article-title":"Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression","volume":"77","author":"Caforio","year":"1997","journal-title":"Heart (British Cardiac Society)"},{"key":"10.1016\/j.autrev.2025.103755_bb0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/eurjhf\/hfq198","article-title":"Arrhythmogenic autoantibodies against calcium channel lead to sudden death in idiopathic dilated cardiomyopathy","volume":"13","author":"Xiao","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.autrev.2025.103755_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/796075","article-title":"Calcium channel autoantibodies predicted sudden cardiac death and all-cause mortality in patients with ischemic and nonischemic chronic heart failure","volume":"2014","author":"Yu","year":"2014","journal-title":"Dis Markers"},{"key":"10.1016\/j.autrev.2025.103755_bb0240","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/cvr\/cvt046","article-title":"Anti-KCNQ1 K(+) channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy","volume":"98","author":"Li","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.autrev.2025.103755_bb0245","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/eurheartj\/ehaa841","article-title":"Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences","volume":"42","author":"Verdonschot","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2025.103755_bb0250","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1038\/s41467-020-16584-z","article-title":"Core functional nodes and sex-specific pathways in human ischaemic and dilated cardiomyopathy","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103755_bb0255","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.autrev.2017.01.012","article-title":"Cardiomyopathy - an approach to the autoimmune background","volume":"16","author":"Becker","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103755_bb0260","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.autrev.2014.08.021","article-title":"Diagnostic and therapeutic aspects of beta1-adrenergic receptor autoantibodies in human heart disease","volume":"13","author":"Bornholz","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103755_bb0265","first-page":"20","article-title":"The ubiquitin proteasome system in ischemic and dilated cardiomyopathy","author":"Sp\u00e4nig","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103755_bb0270","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/FJC.0000000000001264","article-title":"Autoantibodies and cardiomyopathy: focus on Beta-1 adrenergic receptor autoantibodies","volume":"80","author":"Tang","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.autrev.2025.103755_bb0275","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jacc.2016.11.067","article-title":"Myocardial recovery in patients with systolic heart failure and autoantibodies against beta(1)-adrenergic receptors","volume":"69","author":"Nagatomo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2025.103755_bb0280","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/08916934.2018.1514389","article-title":"Immunization with plasmids encoding M2 acetylcholine muscarinic receptor epitopes impairs cardiac function in mice and induces autophagy in the myocardium","volume":"51","author":"Ribeiro","year":"2018","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2025.103755_bb0285","first-page":"14","article-title":"Clinical biochemistry of serum troponin","author":"Gokhan","year":"2024","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"10.1016\/j.autrev.2025.103755_bb0290","doi-asserted-by":"crossref","first-page":"307","DOI":"10.21037\/atm.2017.07.40","article-title":"Anti-cardiac troponin antibodies in clinical human disease: a systematic review","volume":"5","author":"Vilela","year":"2017","journal-title":"Ann Translati Med"},{"key":"10.1016\/j.autrev.2025.103755_bb0295","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12985-015-0257-9","article-title":"Increased frequency of follicular helper T cells in mice viral myocarditis is relevant with anti-ANT antoantibody","volume":"12","author":"Yang","year":"2015","journal-title":"Virol J"},{"key":"10.1016\/j.autrev.2025.103755_bb0300","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.intimp.2009.11.010","article-title":"Neutralization of IL-17 inhibits the production of anti-ANT autoantibodies in CVB3-induced acute viral myocarditis","volume":"10","author":"Yuan","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2025.103755_bb0305","first-page":"499","article-title":"Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy","volume":"116","author":"Wang","year":"2003","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.autrev.2025.103755_bb0310","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1096\/fj.04-3001com","article-title":"Human cardiac myosin autoantibodies impair myocyte contractility: a cause-and-effect relationship","volume":"20","author":"Warraich","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2025.103755_bb0315","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1067\/mhj.2002.124406","article-title":"Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates","volume":"143","author":"Warraich","year":"2002","journal-title":"Am Heart J"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T08:36:53Z","timestamp":1740904613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225000151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1568997225000151"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103755","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequency of autoantibodies and their associated clinical characteristics and outcomes in patients with dilated cardiomyopathy: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103755"}}